Menu
  • Join
  • Login
  • Contact
 

Search abstracts


DESIGN OF ANDROGEN RECEPTOR INHIBITORS USING EXPERIMENTAL (S)-11 AND (R)-9 AS LEADS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
  • Co-author(s): Simona Neykova: Pharmacy, University of Malta, Msida, Malta
    Claire Shoemake: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    Treatment of prostate cancer relies on Androgen deprivation/Androgen Receptor (AR) inhibition. AR mutation causes the condition to become refractory. Literature shows that the Small Androgen Receptor Modulators (SARMs) (R)-9 and (S)-11 are anti-androgens with AR mutant inhibition capability making them viable leads for the management of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses